India's Cadila Healthcare Ltd has received restricted emergency use approval from local regulators to use a Hepatitis C drug as a treatment for moderate COVID-19 in adults, the drugmaker said on Friday.

Cadila gets approval to repurpose Hepatitis C drug for COVID-19 treatment

Indian pharma Cadila Healthcare has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial.

Indian pharma Cadila seeks approval to repurpose Hepatitis C drug for COVID-19

Indian drugmaker Cadila Healthcare Ltd said on Monday it would seek local regulatory approval to treat Covid-19 patients with an already approved Hepatitis C drug, following promising interim results from a late-stage trial.

India's Cadila seeks regulatory approval for Covid-19 drug

A single dose of the hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences' antiviral drug Remdesivir in India to treat COVID-19 following reports of shortages at hospitals.

Zydus Cadila launches India's cheapest Remdesivir version at $37 per vial

Zydus Healthcare estimates that the market size of the two ANDAs put together is nearly US$ 200 million

Indian pharma company buys 2 ANDAs from US drug maker

cadila

Cadila, News on Cadila, stories on Cadila, articles on Cadila, Cadila stories at Wion, Cadila news, Cadila latest news